This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Wall Street Analysts Think Carter Bankshares (CARE) Could Surge 26.44%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 26.4% upside potential for Carter Bankshares (CARE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here's What Key Metrics Tell Us About Carter Bankshares (CARE) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares (CARE) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Carter Bankshares, Inc. (CARE) Beats Q2 Earnings Estimates
by Zacks Equity Research
Carter Bankshares (CARE) delivered earnings and revenue surprises of +32.26% and -0.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares (CARE) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares (CARE) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Carter Bankshares, Inc. (CARE) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Carter Bankshares (CARE) delivered earnings and revenue surprises of 6.67% and 6.92%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Horizon Bancorp (HBNC) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Horizon Bancorp (HBNC) delivered earnings and revenue surprises of 35% and 8.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares (CARE) Surges 5.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Carter Bankshares (CARE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Wall Street Analysts Believe Carter Bankshares (CARE) Could Rally 29.65%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 29.7% in Carter Bankshares (CARE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Carter Bankshares (CARE) Have the Potential to Rally 30.53% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 30.5% upside potential for Carter Bankshares (CARE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Best Value Stocks to Buy for January 24th
by Zacks Equity Research
CMTG, ICL and CARE made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 24, 2025.
Carter Bankshares (CARE) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Carter Bankshares (CARE) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Wall Street Analysts Predict a 31.2% Upside in Carter Bankshares (CARE): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 31.2% upside potential for Carter Bankshares (CARE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Are Options Traders Betting on a Big Move in Carter Bankshares (CARE) Stock?
by Zacks Equity Research
Investors need to pay close attention to Carter Bankshares (CARE) stock based on the movements in the options market lately.
Carter Bankshares (CARE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares (CARE) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Carter Bankshares, Inc. (CARE) Meets Q3 Earnings Estimates
by Zacks Equity Research
Carter Bankshares (CARE) delivered earnings and revenue surprises of 0% and 3.07%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
BCB Bancorp (BCBP) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
BCB Bancorp (BCBP) delivered earnings and revenue surprises of 12.50% and 3.49%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for October 10th
by Zacks Equity Research
CARE, AMTB and GMS have been added to the Zacks Rank #5 (Strong Sell) List on October 10, 2024.
New Strong Sell Stocks for October 3rd
by Zacks Equity Research
BLMN, CJEWY and CARE have been added to the Zacks Rank #5 (Strong Sell) List on October 3, 2024.
New Strong Sell Stocks for September 16th
by Zacks Equity Research
CARE, AMKR and CAL have been added to the Zacks Rank #5 (Strong Sell) List on September 16 2024.
Is the Options Market Predicting a Spike in Carter Bankshares (CARE) Stock?
by Zacks Equity Research
Investors need to pay close attention to Carter Bankshares (CARE) stock based on the movements in the options market lately.
Compared to Estimates, Carter Bankshares (CARE) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Carter Bankshares (CARE) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Carter Bankshares, Inc. (CARE) Meets Q2 Earnings Estimates
by Zacks Equity Research
Carter Bankshares (CARE) delivered earnings and revenue surprises of 0% and 2.31%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Take the Zacks Approach to Beat the Markets: NVIDIA, Seagate, Amkor in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Carter Bankshares (CARE) Soars 5.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Carter Bankshares (CARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Surging Earnings Estimates Signal Upside for Carter Bankshares (CARE) Stock
by Zacks Equity Research
Carter Bankshares (CARE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.